HoxA13 inhibitors are a class of compounds that specifically target and modulate the activity of the HoxA13 protein, a transcription factor belonging to the homeobox (Hox) family. The HoxA13 protein plays a key role in regulating the expression of genes involved in developmental processes and spatial organization during early development. It is part of the Hox gene cluster, which consists of highly conserved genes that guide the formation of body structures along the anterior-posterior axis. By inhibiting HoxA13, these compounds can influence the regulatory pathways governed by this transcription factor, thereby altering the gene networks that control developmental patterning. The molecular mechanisms of HoxA13 inhibition involve the binding of these compounds to specific regions of the HoxA13 protein, disrupting its ability to bind to DNA and regulate gene transcription.
The study of HoxA13 inhibitors offers important insights into the broader functions of Hox genes in developmental biology. These inhibitors serve as valuable tools for dissecting the role of HoxA13 in controlling gene expression during key developmental stages. By blocking the interaction between HoxA13 and its target DNA sequences, researchers can explore how changes in HoxA13 activity affect cellular differentiation, tissue development, and the overall spatial organization of cells. Furthermore, the use of HoxA13 inhibitors helps in understanding the intricate regulatory networks in which this protein operates, shedding light on the genetic and molecular mechanisms underlying developmental processes. The ability to modulate HoxA13 activity through specific inhibitors provides a controlled means of studying the gene regulation dynamics in developmental biology, offering a deeper understanding of the complex interplay between transcription factors and their target genes.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $87.00 | 44 | |
A histone methyltransferase inhibitor that can affect chromatin structure and gene expression, potentially including HOXA13. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $130.00 $270.00 | 37 | |
A histone deacetylase inhibitor that can change chromatin accessibility and may influence HOXA13 expression. | ||||||
Disulfiram | 97-77-8 | sc-205654 sc-205654A | 50 g 100 g | $52.00 $87.00 | 7 | |
An inhibitor of aldehyde dehydrogenase that could affect retinoic acid metabolism, indirectly modifying HOXA13 activity. | ||||||
Histone Lysine Methyltransferase Inhibitor Inhibitor | 935693-62-2 free base | sc-202651 | 5 mg | $148.00 | 4 | |
An inhibitor of histone methyltransferase G9a, which may affect the methylation status of genes and potentially influence HOXA13 expression. | ||||||
5-Aza-2′-Deoxycytidine | 2353-33-5 | sc-202424 sc-202424A sc-202424B | 25 mg 100 mg 250 mg | $214.00 $316.00 $418.00 | 7 | |
A DNA methyltransferase inhibitor that can alter DNA methylation patterns and possibly the expression of HOXA13. | ||||||
Cyclopamine | 4449-51-8 | sc-200929 sc-200929A | 1 mg 5 mg | $92.00 $204.00 | 19 | |
A Hedgehog signaling pathway inhibitor that could indirectly affect homeobox gene expression, including HOXA13. | ||||||
12β-Hydroxydigitoxin | 20830-75-5 | sc-213604 sc-213604A | 1 g 5 g | $140.00 $680.00 | ||
A compound known to modulate multiple signaling pathways, which could have off-target effects on the regulation of developmental genes like HOXA13. | ||||||
Cichoric acid | 70831-56-0 | sc-281636 | 10 mg | $712.00 | ||
An inhibitor of the Wnt/β-catenin signaling pathway which is involved in development and might impact HOXA13 expression. | ||||||
PD173074 | 219580-11-7 | sc-202610 sc-202610A sc-202610B | 1 mg 5 mg 50 mg | $46.00 $140.00 $680.00 | 16 | |
A fibroblast growth factor receptor (FGFR) inhibitor that might indirectly affect HOXA13 due to the role of FGF signaling in limb development. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $182.00 $693.00 | 88 | |
An inhibitor of Rho-associated protein kinase (ROCK) which may have effects on cytoskeletal organization and possibly influence gene expression patterns including HOXA13. | ||||||